Published in Blood Weekly, June 22nd, 2006
Study 1: According to recently published research from the United States, corneal allograft rejection differentially involves CD8+ and CD8- T lymphocytes.
"We examined the role of perforin and FasL in corneal allograft rejection mediated by CD8+ and CD8- T cells. BALB/c corneas were transplanted orthotopically into vascularized, 'high-risk' graft beds in C57BL/6 mice, perforin knockout mice and FasL-defective gld/gld mice," wrote J.Y. Niederkorn and colleagues, University of Texas, Dallas.
They explained, "CD8+ and CD8- T cells were collected...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.